comparemela.com

Latest Breaking News On - Sylvain duranton - Page 5 : comparemela.com

New BCG GAMMA Survey Reveals That Only 9% of Organizations Are Able to Measure Their Total Greenhouse Gas Emissions Comprehensively

/PRNewswire/ Eighty-five percent of organizations are concerned about reducing their greenhouse gas emissions. Measurement is the most significant.

For ethical deployments, companies need to explain and trace AI

Dive Brief: While companies are making progress deploying AI, more than half of enterprises overestimate their levels of maturity in deploying responsible AI models, according to a report from BCG GAMMA, a research group within Boston Consulting Group. The responsible AI framework evaluates the technology s potential effects on safety, privacy and society at large. Almost half of companies fall into the bottom two categories in terms of maturity, with programs that are lagging or in development, according to the report, which collected and analyzed data from senior executives at 1,034 companies with 2,000 employees or more. While 26% of companies say they ve achieved AI deployment at scale, just 12% have fully implemented a responsible AI program as part of their work.

BCG GAMMA, in Collaboration with Scikit-Learn, Launches FACET, Its New Open-Source Library for Human-Explainable Artificial Intelligence

Share this article Share this article BOSTON, Jan. 12, 2021 /PRNewswire/  Boston Consulting Group (BCG) has released its first open-source software library for human-explainable artificial intelligence (AI). BCG GAMMA FACET enables users to make better business decisions by opening the black box of advanced machine learning models. Advances in AI have given data scientists powerful tools to analyze complex business problems and predict outcomes. FACET goes one step further, giving data scientists and business experts a new way to understand how a model arrives at predictions. With this new insight, data scientists can use machine learning models to inform decisions that save money, maximize yield, retain customers, remove bias, and improve patient outcomes.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.